Literature DB >> 12151831

Complications in hysteroscopy: prevention, treatment and legal risk.

Linda D Bradley1.   

Abstract

PURPOSE OF REVIEW: Fortunately, gynecologists are enthusiastically embracing diagnostic and operative hysteroscopy as a means to evaluate women with menstrual disorders, infertility, post-menopausal bleeding, recurrent pregnancy loss, and for ultrasound images. In general, operative hysteroscopy is a safe procedure, is easily learned, and has excellent surgical outcomes. As more obstetricians/gynecologists perform hysteroscopy, they must remain cognizant about the salient complications. The recognition of complications and prompt intervention will prevent adverse sequelae as well as minimizing undesirable patient outcomes and reducing legal risks. RECENT
FINDINGS: Hysteroscopy remains a relatively safe procedure. Diagnostic hysteroscopy has the fewest risks, followed by operative hysteroscopic adhesiolysis, metroplasty, and myomectomy. Fluid management is critical for intraoperative safety. Meticulous detail should be paid to fluid management, and consultation sought with a critical care specialist when fluid overload or hyponatremia is suspected. Lingering pain, fever, or pelvic discomfort after surgery requires prompt evaluation. Women becoming pregnant after operative hysteroscopic procedures need careful antepartum and intrapartum care. Special attention to unusual pain complaints during pregnancy or with fetal distress in labor need prompt intervention.
SUMMARY: The preoperative use of misoprostol or laminara decreases the risk of uterine perforation. Expert preoperative evaluation is essential in determining the surgical skill and expertise needed, surgical time, and the likelihood of completing the operative procedure. Overall, complications in operative hysteroscopy are infrequent and are usually easy to manage. This knowledge should help physicians perform more procedures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151831     DOI: 10.1097/00001703-200208000-00008

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  21 in total

1.  Life-Threatening Laryngeal Edema and Hyponatremia during Hysteroscopy.

Authors:  Barbara Wegmüller; Kerstin Hug; Charlotte Meier Buenzli; Bernd Yuen; Marco Maggiorini; Alain Rudiger
Journal:  Crit Care Res Pract       Date:  2011-03-29

2.  Uses of misoprostol in obstetrics and gynecology.

Authors:  Rebecca Allen; Barbara M O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

3.  Efficacy, safety, and patient acceptability of the Essure™ procedure.

Authors:  Collette R Lessard; Matthew R Hopkins
Journal:  Patient Prefer Adherence       Date:  2011-04-28       Impact factor: 2.711

4.  Reproductive outcome of septate uterus following hysteroscopic septum resection.

Authors:  Priya Selvaraj; Kamala Selvaraj
Journal:  J Hum Reprod Sci       Date:  2010-09

5.  Venous intravasation as a complication and potential pitfall during hysterosalpingography: re-emerging study with a novel classification.

Authors:  Abdurrahim Dusak; Hatice E Soydinc; Hakan Onder; Faysal Ekinci; Neval Y Görük; Cihat Hamidi; Aslan Bilici
Journal:  J Clin Imaging Sci       Date:  2013-12-31

6.  A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

7.  1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings.

Authors:  Mary D Hinckley; Amin A Milki
Journal:  JSLS       Date:  2004 Apr-Jun       Impact factor: 2.172

8.  Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.

Authors:  K S Oppegaard; B-I Nesheim; O Istre; E Qvigstad
Journal:  BJOG       Date:  2008-01-16       Impact factor: 6.531

9.  Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2008-06       Impact factor: 6.531

10.  The use of misoprostol for cervical priming prior to hysteroscopy: a systematic review and analysis.

Authors:  Ying Hua; Wenwen Zhang; Xiaoli Hu; Ansu Yang; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2016-09-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.